Skip to main content
HealixMedical Supply

Nail Health in 2025: Onychomycosis Treatment, Brittle Nails, and Nail Findings as Disease Indicators

By Healix Editorial Team·January 8, 2026·6 min read

Clinical guide to nail health — onychomycosis treatment options (oral terbinafine, efinaconazole, laser), brittle nail causes and management, and nail findings that indicate systemic disease.

Nail disorders affect 10% of the population and are among the most clinically underappreciated conditions — both because they are often misdiagnosed (50% of dystrophic nails diagnosed as onychomycosis are actually other conditions — psoriasis, trauma, or lichen planus) and because they can be the first visible sign of significant systemic disease. A systematic approach to nail assessment — both for cosmetic conditions and as part of a comprehensive physical examination — adds clinical value disproportionate to the time invested.

Onychomycosis: Diagnosis and Treatment

Nail fungal infection (predominantly Trichophyton rubrum) affects 5.5% of the general population and 20% of adults >60. The critical first step: confirm diagnosis before treating. Culture, PAS-stained nail clipping, or PCR (highest sensitivity/specificity) — do not treat empirically as 50% of "thick yellow nails" are not onychomycosis and will not respond to antifungals. Oral terbinafine (Lamisil): 250mg daily × 6 weeks (fingernails) or 12 weeks (toenails). Mycological cure rates: 76–80% for fingernails, 59–70% for toenails — the most effective oral antifungal option. Drug interaction: inhibits CYP2D6 — check interactions before prescribing. Liver toxicity rare but requires monitoring in at-risk patients. Efinaconazole 10% topical (Jublia): FDA-approved topical antifungal for mild-moderate toenail onychomycosis. Mycological cure 53% at 52 weeks versus 17% vehicle — significantly more effective than older topicals (ciclopirox 8% cure rate ~30%). Laser therapy: Nd:YAG laser for onychomycosis — meta-analysis shows modest but real improvement, generally inferior to systemic antifungals but useful when systemic agents are contraindicated.

Nail Signs of Systemic Disease

Terry's nails (2/3 white, 1/3 pink-red distal band): cirrhosis, CHF, DM, aging. Beau's lines (transverse grooves): systemic illness, chemotherapy, zinc deficiency — time the illness by calculating nail growth rate (3mm/month fingernail). Lindsay's nails (half-and-half: proximal white, distal red-brown): chronic kidney disease. Mees' lines (transverse white bands): arsenic poisoning, chemotherapy. Yellow nail syndrome (thickened, yellow-green, slow-growing): lymphedema, pleural effusion, bronchiectasis. Clubbing: chronic hypoxic lung disease, cyanotic congenital heart disease, IBD, hepatic cirrhosis. Nail pitting: psoriasis (>50 pits is highly specific). Longitudinal melanonychia: normally present in darker skin (Fitzpatrick V-VI); new in lighter skin types requires dermoscopy to rule out subungual melanoma. For clinical facilities managing dermatological and systemic conditions, our laboratory supplies section supports nail culture collection and specimen processing.

Medical disclaimer: This article is for general informational purposes only and is not medical advice. Consult a qualified healthcare provider before making decisions about your health or care. Read our editorial policy to learn how this content is researched and reviewed.

Topics:

onychomycosis treatment 2025 clinicalterbinafine efinaconazole nail fungus evidencebrittle nails biotin clinical evidencenail findings systemic disease indicatorsnail health clinical guide dermatology 2025

Need Clinical-Grade Medical Supplies?

Healix Medical Supply stocks 1.5 Million+ FDA-cleared products with bulk pricing for healthcare facilities nationwide.